Pediatrix Medical Group (NYSE:MD) Price Target Cut to $16.00 by Analysts at Truist Financial

Pediatrix Medical Group (NYSE:MD) had its target price reduced by Truist Financial from $18.00 to $16.00 in a research note issued to investors on Friday morning,Benzinga reports. They currently have a hold rating on the stock.

MD has been the topic of a number of other research reports. Macquarie initiated coverage on shares of Pediatrix Medical Group in a research report on Monday, December 16th. They set an “outperform” rating and a $18.00 price target on the stock. UBS Group boosted their target price on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a “neutral” rating in a research report on Friday, February 21st. Finally, StockNews.com raised Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research report on Wednesday, January 22nd. Four analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, Pediatrix Medical Group has a consensus rating of “Hold” and an average price target of $16.75.

Pediatrix Medical Group Stock Down 1.5 %

MD stock opened at $13.35 on Friday. The company has a market cap of $1.15 billion, a price-to-earnings ratio of -11.13, a P/E/G ratio of 1.74 and a beta of 1.32. Pediatrix Medical Group has a twelve month low of $6.62 and a twelve month high of $17.67. The business has a 50 day moving average price of $14.33 and a two-hundred day moving average price of $13.91. The company has a quick ratio of 1.42, a current ratio of 1.60 and a debt-to-equity ratio of 0.81.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings data on Thursday, February 20th. The company reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.12. The firm had revenue of $502.36 million for the quarter, compared to analysts’ expectations of $486.22 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. Analysts anticipate that Pediatrix Medical Group will post 1.38 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. California State Teachers Retirement System lifted its stake in shares of Pediatrix Medical Group by 0.9% during the 4th quarter. California State Teachers Retirement System now owns 80,327 shares of the company’s stock worth $1,054,000 after acquiring an additional 752 shares during the last quarter. Everence Capital Management Inc. increased its holdings in shares of Pediatrix Medical Group by 7.5% in the fourth quarter. Everence Capital Management Inc. now owns 13,840 shares of the company’s stock valued at $182,000 after purchasing an additional 960 shares during the period. Parkside Financial Bank & Trust raised its holdings in shares of Pediatrix Medical Group by 36.1% during the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company’s stock worth $51,000 after purchasing an additional 1,040 shares during the last quarter. Nomura Asset Management Co. Ltd. lifted its holdings in Pediatrix Medical Group by 95.3% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company’s stock valued at $33,000 after acquiring an additional 1,220 shares during the period. Finally, AlphaQuest LLC raised its position in shares of Pediatrix Medical Group by 65.9% in the fourth quarter. AlphaQuest LLC now owns 5,066 shares of the company’s stock worth $66,000 after acquiring an additional 2,012 shares during the period. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.